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Abstract
The literature on the magnetosome membrane (MM) protein, magnetosome membrane speciﬁc6 (Mms6),
is reviewed. Mms6 is native to magnetotactic bacteria (MTB). These bacteria take up iron from solution and
biomineralize magnetite nanoparticles within organelles called magnetosomes. Mms6 is a small protein
embedded on the interior of the MM and was discovered tightly associated with the formed mineral. It has
been the subject of intensive research as it is seen to control the formation of particles both in vivo and
in vitro. Here, we compile, review and discuss the research detailing Mms6’s activity within the cell and in a
range of chemical in vitromethodswhereMms6 has amarked effect on the composition, size and distribution
of synthetic particles, with approximately 21 nm in size for solution precipitations and approximately 90 nm
for those formed on surfaces. Furthermore, we review and discuss recent work detailing the structure and
function of Mms6. From the evidence, we propose a mechanism for its function as a speciﬁc magnetite
nucleation protein and summaries the key features for this action: namely, self-assembly to display a
charged surface for speciﬁc iron binding, with the curvature of the surfaces determining the particle size.
We suggest these may aid design of biomimetic additives for future green nanoparticle production.
Introduction
Nanoscale inorganic materials are important in an increas-
ingly nanotechnological world. More specifically, magnetic
nanoparticles (MNPs) have wide ranging uses from targeted
drug delivery [1], to ultrahigh-density data storage [2].
Magnetite MNPs are particularly useful for biomedical
applications such as MRI contrast enhancers for diagnostics,
magnetically targeted treatments and magnetic hyperthermia
therapy [1,3,4]. However, the reliable production of highly
specific monodispersed MNP is a considerable challenge
making new synthetic routes to precisely tailored MNPs a
necessity [3].
Natural organisms carefully control the production of
a vast range of inorganic minerals in a process called
biomineralization [5,6]. For example organisms use calcium
phosphate to form bones and teeth, calcium carbonate to
make shells and diatoms produce shells and spines from silica
[5,6]. Remarkably, nature offers precise genetic control over
mineral formation (down to the nanoscale) using a suite of
biomineralization proteins [5,6]. Harnessing these proteins
presents a biological (ambient condition) synthetic approach
to producing tailored MNPs.
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The most studied magnetotactic bacteria (MTB) are
aquatic, motile, microaerobic microbes that take up soluble
iron ions and crystallize magnetiteMNPswithin intracellular
liposomes (magnetosomes) (Figure 1b) [7,8]. However, MTB
are found across the phylogenetic tree, leading to bacteria
with variable phenotypes. These range from anaerobic to
aerobic, micron-sized Cocci, Vibrio and Spirilla [9], to giant
10 μm rods containing 1000’s of magnetosomes [10], living in
environments from fresh water to saline [11], whereas some
MTB even produce greigite MNP or both magnetite and
greigite [12]. Early reviews, such as Bazylinski and Frankel
[8] and Frankel et al. [13], offer comprehensive descriptions
of MTB and their magnetosomes. Magnetosomes’ size and
morphology vary greatly between strains too, but is highly
uniform within each strain, demonstrating the control that
biomineralization proteins must have over this process. The
mechanism of biomineralization in MTB enjoys extensive
research and is the subject of several concise overview reviews
[7,14,15], and amore specific reviewof themagnetosomes [16]
and of their protein’s predicted structure and function [17].
Briefly, the magnetosome membrane (MM) is proposed to
form through invaginationof the cytoplasmicmembrane [18],
with recruitment and insertion of unique biomineralization
proteins into or on to the membrane [14,18]. These include:
iron transporters [19,20], redox proteins [21] that ensure the
chemistry of magnetite formation is enabled, and nucleation
and shape controlling proteins [22,23] that ensure that
magnetite is crystallized and grows in the correctmorphology
[17]. We have been interested in understanding how these
proteins (particularly the latter) control magnetite MNP
formation and how we can best utilize them (and their
mimics) for bio-mediated MNP formation for applications.
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Figure 1 The sequence of Mms6 and its activity demonstrated in vivo and in vitro
(a) Sequence alignment of the truncated Mms6 from different MTB species (the full pre-protein amino acid; numbering
is shown above and the mature truncated amino acid position for M. magneticum AMB-1; Mms6 is shown below the
alignment). Conserved residues are highlighted in red boxes and similar residues are in red type, showing a highly conserved
truncated protein. The initial approximately 98 residues (assumed absent from the mature protein) are not shown but are
less conserved (or missing in the case of M. blakemorei). The blue bar highlights the glycine–leucine repeating sequence
and the yellow bar highlights the hydrophilic, acid rich, C-terminal amino acid region. (b) Demonstrates the activity of Mms6
in vivo through an mms6 knockout mutant in AMB-1[23]. Note the MNPs formed in the cell with mms6 absent are smaller
and ill formed. (c) Demonstrates the activity of Mms6 in vitro by comparing magnetite MNPs formed in a simple RTCP
(protein-free control) with those formed under the same condition but with the addition of Mms6 [24]. Figures 1(b) and 1(c)
reproduced from [24]: Amemiya, Y., Arakaki, A., Staniland, S.S., Tanaka, T. and Matsunaga, T. (2007) Controlled formation of
magnetite crystal by partial oxidation of ferrous hydroxide in the presence of recombinant magnetotactic bacterial protein
Mms6. Biomaterials 28, 5381–5389.
There has been considerable analysis of one such protein
(magnetosome membrane specific6; Mms6), and this is the
subject of this mini-review.
Mms6 in vivo
To understand the molecular elements which control
magnetite biomineralization there have been a number of
studies of both the genomes and proteomes of different MTB
and in particular of those elements closely associated with the
formation of the magnetosome itself [18,25–29]. Analysis of
these sequences has shown that themajority of genes involved
in magnetosome biogenesis can be grouped into four key
operons (mms6, mamGFDC, mamAB andmamXY clusters)
in a region of the genome termed the magnetosome island
(MAI) [18,28–34]. If the MAI is lost from MTB then the
magnetic properties are also lost [31] and vice versa, if these
key operons are transferred to non-magnetic bacteria, then
they also develop the ability to produce biogenic magnetic
nanocrystals [30].
The discovery of Mms6 was reported in 2003 in a
pioneering study by Arakaki et al. [35]. The magnetosomes
from Magnetospirillum magneticum AMB-1 were magnet-
ically extracted from lysed cells and the lipid membrane
component of the magnetosome removed [35]. The bare
magnetite nanocrystals were subjected to further treatment
with detergent and heat to release proteins tightly associ-
ated. Four proteins were found: magnetosome membrane
specific5 (Mms5),magnetosomemembrane specific7 (Mms7),
magnetosome membrane specific13 (Mms13) and Mms6, all
so-called for their magnetosome membrane specific (Mms)
localization and the number denotes their apparentmolecular
mass [35]. Mms6 has an overall net negative charge at neutral
pH, in contrast with the positive charge of the other isolated
Mms proteins [35]. Mms6 has been detected in the MM
fraction by both 2D SDS/PAGE [25] and shotgun protein
identification [18], but not in any of the other membrane
fractions of the cell [18], suggesting this protein is specifically
targeted to the MM.
The gene sequence of Mms6 is present in several strains
of MTB with a high level of consensus, particularly in the
C-terminal region (Figure 1a). The sequences code for a
protein of approximately 12–15 kDa, much larger than the
6 kDa species isolated directly from magnetosomes [25,35].
The sequenceharbours a glycine–leucine repeatmotif (cyan in
Figure 1a) and an acid rich C-terminal region (yellow
in Figure 1a). It is speculated that Mms6 is processed
in vivo by a specific protease to form the 6 kDa truncated
protein (Figure 1a) [25,35]. It is interesting to note that in
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Magnetovibrio blakemorei the mms6 sequence appears to
encode only the truncated form of Mms6 which lacks this
N-terminal region [36], which would suggest this part of
Mms6 is not required for effective magnetite biomineraliza-
tion.
A number of gene knockout studies have been performed
to assess the specific effect that Mms6 has on magnetite
biomineralization [22,23,26]. When the mms6 gene was
knocked out in M. magneticum AMB-1, the resulting
particles were found to be poorly defined and smaller
in size, with an average reduction in diameter of 44%
[22] compared with wild-type particles. More recent and
previous studies with Δmms6 strains have shown similar
results with approximately 19% reduction in AMB-1 strains
[23] (Figure 1b) and a 15% reduction in Magnetospirillum
gryphiswaldense, indicatingMms6 is required for production
of full-sized nanocrystals [26]. Discrepancies in the particle
size reduction resulting from mms6 gene knockouts in
different studies may be due to how these knockouts have
been performed. The 44% reduction is as a result of an
antibiotic resistance cassette insertion in the mms6 gene,
whereas other studies use two-step recombination to delete
mms6. The cassette insertion could inadvertently result in
a more pronounced effect by disrupting the production of
downstream gene products which have also been implicated
in particle formation [23]. There also appears to be a general
loss of shape control when Mms6 is absent [22,23,26].
High resolution transmission electronmicroscopy (HRTEM)
analysis of wild-type nanoparticles shows the presence of
cubo-octahedral morphology with the characteristic (100)
and (111) crystal faces [22,24,37]. In contrast, a Δmms6
mutation produces particles bearing the high energy (110)
face of magnetite [22], generally considered to be unstable
[22]. This may demonstrate the crystallization process is
unfinished in this mutated strain. A key phenotype observed
inΔmms6 strains are particles with an elongatedmorphology
(Figure 1b). Wild-type magnetosomes of M. magneticum
AMB-1 produce particles with a shape factor (ratio of length
to width) close to 1, but in Δmms6 cells this is 0.75 [22,23].
As well as the effects on the nanoparticle itself, the lack of
Mms6 in the magnetosome also reduces the level of other
magnetosome associated proteins including Mms13, 5 and 7.
Mms6 is therefore clearly implicated in protein recruitment to
the magnetosome [22], and the N-terminal portion of Mms6
is a likely contender for mediating these contacts.
Producing MNPs with Mms6 in vitro
Additional to its natural activity within the magnetosomes
of MTB, purified Mms6 has been investigated in synthetic
magnetite formation reactions to look for effects on the
MNP products [24,35,38–43]. Magnetite (Fe3O4) contains
both ferric (Fe3+ ) and ferrous (Fe2+ ) iron in a precise
stoichiometric ratio of 2:1. There are several methods
of producing magnetite synthetically but most rely on
providing (or producing during the reaction) a mixture of
iron of both valences and bringing about its subsequent
precipitation by raising the pH. By including purified
Mms6 to these syntheses, the size, shape and material
purity of the resulting nanoparticles can be compared with
protein-free nanoparticles prepared under identical condi-
tions [24,35,38,40]. The nature of the magnetite precipitation
process within the magnetosome has not been completely
chemically resolved and remains one of the key barriers
to our fuller understanding of magnetite biomineralization.
However, a recent well conducted study has gone some way
to answering this point [44]. Firlar et al. [44] used single
particle analysis of forming magnetosomes to show that a
ferric-rich amorphous precursor is formed initially, before
conversion to the final magnetite species. It is therefore
likely that the current approaches for studying Mms6
activity synthetically share similarities with the processes
and conditions under which Mms6 would normally function
(Table 1).
The majority of studies have explored two methods
of magnetite synthesis with Mms6: these are the room
temperature co-precipitation (RTCP) and partial oxidation
of ferrous hydroxide (POFH). In 2003, the first in vitro
activity of Mms6 was reported by Arakaki et al. [35].
The authors found that addition of Mms6 to an RTCP
reaction (Mms6 at 20 μg/ml) resulted in a product which
contained mainly magnetite and little alternative iron
oxide compared with the protein-free control sample. The
alternative iron oxides formed in the control reaction suggests
a relatively uncontrolled precipitation reaction occurred
in this experimental system. However, this highlights the
ability of Mms6 to shift the balance of products towards
magnetite in such a reaction.Additionally, theMms6prepared
particles displayed a narrower size distribution and a cuboidal
appearance very similar to that observed in magnetosomes.
Similar results have been replicatedwith lower concentrations
of protein [24] (Figure 1c), different ratios of ferrous to ferric
iron in the reactionmixture [41], as well as in POFHreactions
[24,41] and with Mms6 immobilized on planar surfaces to
mimic the magnetosome interior [40]. The general trends
(Table 1) are that the addition of Mms6 in solution produces
nanoparticles of approximately 21 nm while also reducing
their size distribution, regardless of the protein-free particle
size population [with the exception of the partial oxidation of
ferrous hydroxide with ammonia and hydrazine (POFHN)].
Interestingly, the only instance when Mms6 mediated
particles are of a different size is in a particular partial
oxidation of ferrous hydroxide with potassium hydroxide
(POFHK) reaction where the control MNPs has a huge
size distribution [41]. These reactions are very sensitive to a
variety of reaction parameters. In this case, the Mms6 MNPs
are an average of 42 nm in size, however if the distribution
is examined more closely it can be seen there is a dual
population, with one peak the same size as the other Mms6
mediated MNPs (22.5 nm) and the remaining peak similar to
the control particles (Table 1) [41], showing Mms6 is able
to control a portion of the population, perhaps suggesting the
ratio ofMms6 to iron is insufficient. Significantly, on surfaces
the particles produced with Mms6 are approximately 90 nm
c© 2016 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution Licence
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Table 1 Summary of MNPs produced in Mms6 mediated reactions
*Brackets denote the ratio of ferric to ferrous ions used.
Mms6
construct
MNP synthesis
type
MNP size
(nm)
Size
distribution
(σ ) (nm)
Control size and
distribution (nm) Reference
Mms6 in solution Mms6 RTCP (1:1)* 20–30 – 10 with a range 1–100 [35]
21.2 8.3 [24]
Mms6 RTCP (1:2)* 22.3 5.2 Asymmetric, peak
8.7 with range 1–90
[41]
His6–Mms6 21.9 6.0
Mms6 POFHK 42 22.5 (second
peak
136± 27.8)
Asymmetric, peak 164
with range 1–600
[41]
Mms6 20.3 3.2 27.5 with range 10–40 [39]
Mms6 20.7 3.6 35.5± 6.4 [24]
Mms6 POFHN 145 68.8 Bimodal (peak 59 and
400) range 0–600
[41]
Surface immobilized Mms6 86 21 64 ± 26 [45]
His8–Mms6 POFHK 90 15 69 ± 36 [46]
87 19 60 ± 21 [40]
Mms6 POFHN 340 54 230 ± 121 [43]
Mms6 POFHN (dilute) 231 47 154 ± 63
Mms6 in pluronic gel His6–Mms6 RTCP (2:1)* 30 – [38]
Mms6 peptide in solution M6A POFHK 22.8 3.3 27.5 with range 10–40 [39]
GLM6A 20.0 3.1
Surface immobilized Mms6
peptide
Mms6–pep POFHK 65 30 60 ± 21 [40]
and therefore much larger than the protein-free particles,
perhaps due to the planar arrangement of Mms6 compared
with the curvedmicelles in solution.During POFHreactions,
the system is heated (to approximately 80 ◦C), at which point
most proteinswould be denatured and inactive, yetMms6 has
an effect in such reactions. However, the heating is performed
once all the reagents are supplied and the particles have
begun to precipitate, indicating that Mms6 may either only
function at the particle nucleation stage (prior to heating), or
be remarkably resilient to such treatment.
Mms6 in vitro: understanding its function
It is clear from the previous section that Mms6 is able to
control the formation of magnetite MNPs when added to
a chemical precipitation. Taken together we believe we can
describe the action of Mms6 in vitro and thus propose a
mechanism for its function.
Self-assembly
The amphiphilic nature of Mms6 (Figure 1a) implies it
will form micelles in aqueous solution with the C-terminal
hydrophilic regions exposed, shielding the hydrophobic N-
terminal regions within the core. This structure was first
quantitatively investigated by Wang et al. [47] who found
through size-exclusion chromatography that the micelle was
between 200–400 kDa made up of 20–40 protein subunits.
Dynamic light scattering (DLS)measurements foundmicelles
were 10.2± 3 nm across, equating to approximately 200 kDa,
in agreement with the other analysis [47]. At pH 7.5, they
have a slightly narrower elution profile than those at pH 3.
The structure and size was further confirmed through SAXS
experiments [48]. Using a core-corona model, the data fitted
well to a hydrophobic core of radius 3.9 ± 0.4 nm and
hydrophilic corona radius of 1.1 ± 0.2 nm parameters
at pH 3. Again there is a difference at pH 7.5, but the
modelled parameters are not given. Interestingly, they found
that addition of iron caused the micelles to form higher
order structures such as discs of micelles [48] (Figure 2a)
presumably through iron cross-linking.Most recently,Mms6
micelles (or larger proteinaceous assemblies) have been
visualized in situ in fluid cell TEM [49] where the micelles
appear approximately 10-fold larger (Figure 2b). Wang et
al. [47] indicated a small population of much larger protein
assembly particles in SEC, so it is not unreasonable to
assume these will be the easiest to visualize in the fluid cell
TEM. Perhaps trace iron is causing a small amount of larger
assembly.
It is remarkable that Mms6 is able to convey similar
activity/control over magnetite MNP formation in vitro
as in vivo, leading to the conclusion that there must be
some degree of self-assembly in the membrane environment,
c© 2016 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution Licence
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Figure 2 Summary of the self assembly and iron binding properties of Mms6 along with schematic representations of the proposed
function
Summary of the research on the (1) micellar structure (a) and (b), (2) schematic representations to describe its function
and mechanism for nucleation (c) and assembly (d) and (3) iron binding (e) and (f) of Mms6. (a) shows a model for
the micelle structure obtained by SAXS analysis [48]. (b) shows the nucleation and precipitation of iron oxide MNP (bright
spots) on the surface of an Mms6 micelle (scale bar 20 nm) [49]. (c) An above view schematic of how Mms6 may
self-assemble as a protein raft to display regular binding sites for iron ions to nucleate magnetite formation. (d) Side-on
schematic to demonstrate how the curvature of the protein surfaces differs for the (i) in solution micelles, (ii) on a surface
and (iii) on the MM to explain for difference seen in particle size [40]. (e) Size of chemical shifts of residues upon metal
binding in Mms6 C-terminal peptide from 2D NMR analysis. Green bars represent ferrous ions [51]. (f) Ferric iron binding
analysis of Mms6 (), Mms6 with the C-terminus shufﬂed () and Mms6 with just the acidic residues in the C-terminus
shufﬂed () [47]. Figure 2(a) reproduced from [48]: Zhang, H., Liu, X., Feng, S., Wang, W., Schmidt-Rohr, K., Akinc, M.,
Nilsen-Hamilton, M., Vaknin, D. and Mallapragada, S. (2015) Morphological transformations in the magnetite biomineralizing
protein Mms6 in iron solutions: a small-angle X-ray scattering study. Langmuir 31, 2818–2825. Figure 2(b) reproduced from
[49]: Kashyap, S., Woehl, T.J., Liu, X., Mallapragada, S.K. and Prozorov, T. (2014) Nucleation of iron oxide nanoparticles
mediated by Mms6 protein in situ. ACS Nano 8, 9097–9106. Figure 2(d) reproduced from [40]: Bird, S.M., Rawlings, A.E.,
Galloway, J.M. and Staniland, S.S. (2016) Using a biomimetic membrane surface experiment to investigate the activity
of the magnetite biomineralisation protein Mms6. RSC Adv. 6, 7356–7363. Figure 2(e) reproduced from [51]: Rawlings,
A.E., Bramble, J.P., Hounslow, A.M., Williamson, M.P., Monnington, A.E., Cooke, D.J. and Staniland, S.S. (2016) Ferrous iron
key to Mms6 magnetite biomineralisation: a mechanistic study to understand magnetite formation using pH titration and
NMR. Chem. Eur. J. 22, doi:10.1002/chem.201600322. Figure 2(f) reproduced from [47]: Wang, L., Prozorov, T., Palo, P.E.,
Liu, X., Vaknin, D., Prozorov, R., Mallapragada, S. and Nilsen-Hamilton, M. (2012) Self-assembly and biphasic iron-binding
characteristics of Mms6, a bacterial protein that promotes the formation of superparamagnetic magnetite nanoparticles of
uniform size and shape. Biomacromolecules 13, 98–105.
similar to the aggregation seen in vitro. We propose Mms6
is not monomeric in the MM, but self-assembles to form
protein rafts on the MM interior, displaying a charged C-
terminal surface (schematic Figure 2c) akin to the surface of
in vitro micelles (but of the opposite curvature) (schematic
Figure 2d). We tested this hypothesis by enabling Mms6
to self-assemble on a surface, mimicking the membrane
environment. Remarkably, the biomimetic Mms6 surface
nucleated and controlled magnetite formation, whereas the
C-terminal peptide alone (C20Mms6) did not [40]. C20Mms6
is missing the N-terminal region but is still able to assemble
on the surface [40]. Thus, we propose that the nature of self-
assembly in Mms6 is more specific than generic hydrophobic
interactions. A glycine–leucine repeating sequence is present
in the conserved 6 kDa protein (but absent from C20Mms6)
(Figure 1a). Such motifs are common in self-assembling
structural proteins e.g. silk fibroin [40,50]. We propose this
knob and hole arrangement of hydrophobic residues could
interlock with adjacent Mm6 molecules (and even in vivo to
other Mms proteins with the same glycine–leucine motif) to
c© 2016 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution Licence
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form a regularly packed structure and thus regularly space
the iron binding C-terminal sites across a raft surface of
Mms6 (schematic in Figure 2c). It appears that without this
the magnetite nucleation ability is lost, as the C20Mms6 on
surfaces demonstrates (compare in Table 1) [40]. In solution,
the peptide has shown an effect on particle formation, but
this could be driven by some level of aggregation in solution
[39]. Interestingly, a peptide constructed of a GL-C6Mms6
repeat fusion (GLM6A) shows better control over particle
formation (Table 1), further demonstrating the importance of
this region [39].
Study through the formation process in situ
We propose Mms6 self-assembles in a uniform manner to
display a regular array of the acidic C-termini, create a
negatively-charged surface for iron ion binding to nucleate
magnetite formation. However, tracking and analysing this
process is not trivial. Recently, Kashyap et al. [49] showed
iron oxide nucleation on the surface of the Mms6 micelles
in situ in a fluid TEM experiment. Remarkably, ferric ion
association with Mms6 from low pH can clearly be seen,
and as the pH rises small iron oxide particles visibly form
across the micelle surface (Figure 2b). They note some ferric
ion depletion when the pH initially rises, attributed to a
first step in forming a disordered pre-nucleation phase [49].
However, the pH is not quantified for each imaging stage, and
only ferric ions are used so the mineral nucleated would not
ultimately crystallize to magnetite. Therefore, tracking the
chemistry quantitatively throughout the process is essential
to understand the effect the protein is having on magnetite
formation. We performed a series of pH titrations on the
in vitro precipitation of magnetite with and without Mms6
and found that Mms6 had no effect on the process below
pH 4 for a range of different ferric:ferrous ratios [51]. This is
the stage where the more insoluble ferric ions precipitate as
a ferric oxide (such as schwertmannite in our case, but could
be haematite or ferrihydrite depending on the conditions).
Although studies do show that ferric ions can bind toMms6 at
pH 3, it is considerably less than at pH 7 [47]. Thus,webelieve
binding at low pH is not the main action of Mms6, being
negligible when compared with the bulk precipitation. Only
after this precipitation stage does the Mms6 pH trace diverge
from the protein-free reaction when the mixed valance iron
oxides start to precipitate, corroborating the idea that Mms6
is most active at higher pH when the acidic groups are most
available for iron binding [51]. Interestingly, we see Mms6
has the most marked effect in ferrous-rich ferric:ferrous
ion ratios, indicating increased magnetite production with
Mms6 (20%) compared with negligible amounts without
protein, suggesting Mms6 is able to direct mineralization
towards magnetite synthesis under conditions further from
the ideal for magnetite formation, effectively acting as a
‘mineral/ferrous ion buffer’ [51]. Furthermore, it appears that
Mms6’s interaction with ferrous ions is potentially crucial to
this process.
Fe binding
The iron binding ability of Mms6 was first reported by
Arakaki et al [35]. Using a competitive radioactive ferric
ion binding assay where purified recombinant Mms6 was
seen to bind Fe3+ , Ca2+ and Mg2+ , but not Zn2+ , Ni2+
or Cu2+ , showing some metal selectivity [35]. Most Mms6
iron binding studies have been performed with ferric ions
[35,47,49] which have limited solubility at physiological pH.
Chelators such as citrate are therefore required to solubilize
Fe3+ for analysis at neutral pH. High affinity ferric ion
binding (Kd=10− 16 M) was established at pH 7.5 in this
way, whereas mutants (with scrambled C-termini) show no
significant ferric binding, demonstrating the importance of
the amino acid sequence at the C-termini (Figure 2f) [47].
To facilitate an increase in ferric ion concentration, further
assays were performed at pH 3 where ferric ions are soluble.
A significantly lower binding affinity of Kd=0.58 ± 0.03 μM
was reported [47]. At low pH, the acidic groups of Mms6
are likely to be mostly protonated (pKa of free glutamic
acid is approximately 4) reducing the capacity to bind ferric
ions. As the pH increases to 7 (where mixed valence iron
minerals precipitate), deprotonation will produce negatively-
charged acidic groups compatible with iron ion binding.
Mms6 shows variations in iron ion binding and micelle
morphology between low and neutral pH demonstrating
the significance that pH has [48]. pH measurements during
RTCP with Mms6 further demonstrates this point, showing
Mms6 has minimal effect at pH<4 [51]. NMR analysis of
the C20Mms6 peptide in the presence and absence of ferric
ions (at pH 7) revealed only small chemical shift differences
in the peptide side chains [51]. However, in the presence of
ferrous ions significant (5-fold) chemical shift differences are
seen (Figure 2e) indicating stronger, more specific binding of
ferrous than ferric iron [51]. Molecular modelling suggests
ferric ions may bind non-specifically (drawn to the areas
of greatest charge) so the binding does not significantly
change C20Mms6’s conformation, but ferrous ions display
specific multisite binding suggesting C20Mms6 is a specific
multidentate ferrous ion ligand [51].
Discussion and conclusion: proposed
mechanism of function
In vitroMms6 showsnegligible activity inRTCPexperiments
below pH 5 as determined by pH monitoring in situ [51].
When deprotonated the 10–12 nm sized Mms6 micelles are
likely to display negatively-charged surfaces for iron binding.
We propose that Mms6 binds both ferric and ferrous ions
under these conditions; ferrous seemingly specifically [51],
whereas the highly charged Fe3+ bindsmore indiscriminately
and abundantly [47–49]. The acidic residues of the C-
terminal region of Mms6 may concentrate mixed valence
iron on the surface in the correct 1:2 ratio to nucleate
magnetite. However, the C20Mms6 peptide appears unable
to nucleate magnetite as effectively [40], suggesting Mms6
function requires some degree of ordered self-assembly. The
c© 2016 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution Licence
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structural glycine–leucine repeat sequence may provide this
by achieving interlocked packing between Mms6 subunits to
bring about a large charged surface for the specific positional
binding of Fe2+ to 2x Fe3+ to encourage the nucleation of
magnetite [39,40].
The action of Mms6 in vivo may be similar to that
observed in vitro. Instead of micellar assembly, Mms6 may
assemble in the MM in a raft-like form [Figures 2c and 2d
(iii)]. Although the pH inside magnetosomes has not been
determined, it must be high enough to enable magnetite to
precipitate and thus for Mms6 to be active. It is thought
that iron is transported into magnetosomes as Fe2+ [52–
54] with subsequent partial oxidation to Fe3+ by oxidase
enzymes. In in vitro experiments, Mms6 is most influential in
ferrous-rich conditions [51], where magnetite is chemically
more challenging to produce. This may reflect the conditions
within the magnetosome.
Whether or not Mms6 is a nucleating or shape controlling
protein is debated [17,22,39,40,49]. Iron ion binding data
[47–49] and poor binding activity betweenmagnetite surfaces
and Mms6 [40] show it is only tightly bound if involved at
the nucleation stages. But in vivo, mms6 knockout studies
show poorly formed, smaller, magnetite crystals, supporting
morphology controlling activity [22,23]. However, the
more recent studies have found less clear effects on particle
morphology when mms6 is deleted [23]. One possibility to
account for these conflicting reports is that neighbouring
genes, in particular mmsF, may be affected by the gene
knockout in the earlier study. MmsF has been described as
a master regulator of magnetite biomineralization in vivo
[23]. However, it is likely that morphology and nucleation
activities are coupled; if a particle is not nucleated properly,
it may not form to the desired morphology. Equally
nucleation from a specific crystal plane will guide the
eventual morphology of the final nanoparticle.
It is clear that Mms6 regulates the size of particles in vitro;
with consistent size across both RTCP and POFHK routes
(21 nm) when nucleated on Mms6 micelles in solution
[24,35,39,41], and particles approximately 90 nm in size
when nucleated by Mms6 assembled on planar surfaces
[40,45,46],whereasMNPswithinmagnetosomes are typically
40–50 nm [55]. The key difference between all these surfaces
is curvature, from convex to flat to concave respectively. We
suggest this difference in degree and angle of contact between
the protein assembly surface and the mineral (along with
nucleation physics) is responsible for the difference in particle
sizes (Figure 2d and Table 1) [40].
Mms6 activity in vitro holds promise for biokleptic
synthesis for nanotechnology [56]. However, Mms6 is
not trivial to produce, making scale-up for commercial
processes unlikely. An understanding of Mms6 informs
the design of additives for MNP production to mimic the
function of Mms6. We propose that the key elements for
design should be: (1) negatively-charged carboxylate-rich
surface, (2) a precisely packed assembly of this surface
and (3) MNP size may be tuneable by controlling surface
curvature.
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